Home » Topics » BioWorld Science

BioWorld Science
RSS

Enterovirus contributes to islet autoimmunity

Dec. 11, 2019

Killer T cells protected by membrane lipid order and charge

Dec. 11, 2019

Orca opens phase Ib study of TregGraft in hematologic malignancies

Dec. 10, 2019

Sinovent studies small-molecule human URAT1 inhibitor XNW-3009 in phase I

Dec. 10, 2019

FDA removes clinical hold on Abeona's phase III VIITAL study of EB-101

Dec. 10, 2019

LAIMU synthesizes new compounds for allergy

Dec. 10, 2019

Gilead Sciences identifies new benzamides for liver diseases

Dec. 10, 2019

Nerviano Medical Sciences presents new IDH1 and/or IDH2 mutant inhibitors

Dec. 10, 2019

Indivior selects CRO to conduct phase I study of INDV-2000

Dec. 10, 2019

Guangzhou Henovcom Bioscience discloses ENPP2 inhibitors

Dec. 10, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
BIO 2026: Alternatives to funding orphan drugs
BioWorld
At the BIO International Convention, nonprofit and for-profit companies discussed ways to fund orphan drug development, especially for ultra-rare diseases where...
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...